Content Restricted
This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.
Purchase Standard Account
Between the third quarter 2016 and the third quarter of 2018, the number of nurse practitioners (NPs) with a waiver to prescribe buprenorphine rose from 23 in the third quarter of 2016 to 340 in the third quarter of 2018. Before the 2016 Comprehensive Addiction and Recovery Act (CARA) went into effect, only physicians could qualify for a waiver to prescribe buprenorphine. After CARA went into effect, NPs and physician assistants (PAs) could also qualify for a waiver.
Between the first quarter of 2015 and the third quarter of 2018, the number of consumers receiving buprenorphine prescriptions to treat opioid . . .
